Clinical Trial Details
| Trial ID: | L0090 |
| Source ID: | NCT03361280 |
| Associated Drug: | Beta Blocker |
| Title: | Removal of Beta Blocker Drugs by Hemodialysis |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Chronic Kidney Diseases |
| Interventions: | DRUG: Beta blocker |
| Outcome Measures: | Primary: Dialytic Clearance, Dialytic clearance calculated by the recovery clearance method, Through study completion, average of one year. | Secondary: Dialytic Clearance, Dialytic clearance calculated by the arteriovenous difference method, Through study completion, average of one year. |
| Sponsor/Collaborators: | Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE1|PHASE2 |
| Enrollment: | 8 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: BASIC_SCIENCE |
| Start Date: | 2015-02-27 |
| Completion Date: | 2016-03-10 |
| Results First Posted: | |
| Last Update Posted: | 2017-12-04 |
| Locations: | |
| URL: | https://clinicaltrials.gov/show/NCT03361280 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|